ClearPoint Neuro Inc
Research ClearPoint Neuro Inc (CLPT) on Bullrun: market cap USD 517.33M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCLPT
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 517.33M
- Financial periodQ2 2026
- RevenueUSD 10.88M
- Net income-USD 11.34M
- Free cash flow-USD 7.23M
- Gross margin61.7%
Valuation Snapshot
latest market cap is USD 517.33M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 36.97M | -USD 25.54M | -USD 24.42M | 61.4% | -0.9 | USD 45.92M | USD 49.08M | USD 28.02M |
| FY2024 | USD 31.39M | -USD 18.91M | -USD 9.23M | 60.9% | -0.7 | USD 20.10M | USD 3.57M | USD 25.39M |
| FY2023 | USD 23.96M | -USD 22.09M | -USD 14.44M | 56.8% | -0.9 | USD 23.14M | USD 9.95M | USD 21.17M |
| FY2022 | USD 20.55M | -USD 16.44M | -USD 16.42M | 65.8% | -0.68 | USD 27.62M | USD 9.89M | USD 36.89M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 517.33M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 401.77M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 424.76M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 167.17M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 207.98M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 265.53M | n/a | n/a | n/a |
About ClearPoint Neuro Inc
ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which consist of SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow Neuro cannula.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is ClearPoint Neuro Inc's market cap?
ClearPoint Neuro Inc's market capitalization is USD 517.33M.
What does ClearPoint Neuro Inc do?
ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which consist of SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow Neuro cannula.